Jump to ContentJump to Main Navigation

You are looking at 1-10 of 10 items

  • Keywords: drug prices x
Clear All Modify Search

View:

From “Recycled Molecule” to Orphan Drug: Lessons from Makena

Kate Greenwood

in FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies

Published in print:
2015
Published Online:
May 2016
ISBN:
9780231171182
eISBN:
9780231540070
Item type:
chapter
Publisher:
Columbia University Press
DOI:
10.7312/columbia/9780231171182.003.0026
Subject:
Law, Medical Law

In 2011, the Food and Drug Administration made the controversial decision not to enforce the Orphan Drug Act’s period of market exclusivity for Makena (hydroxyprogesterone caproate injection), ... More


Why Do the Japanese Spend So Much on Drugs?

Seiritsu Ogura and Takehiko Hagino

in Labor Markets and Firm Benefit Policies in Japan and the United States

Published in print:
2003
Published Online:
February 2013
ISBN:
9780226620947
eISBN:
9780226620954
Item type:
chapter
Publisher:
University of Chicago Press
DOI:
10.7208/chicago/9780226620954.003.0010
Subject:
Economics and Finance, South and East Asia

This chapter examines the disproportionately high spending on pharmaceuticals in Japan. It presents evidence regarding the effects of price distortions on resource allocation in the health care ... More


Pharmaceutical Prices

Stuart O. Schweitzer and Z. John Lu

in Pharmaceutical Economics and Policy: Perspectives, Promises, and Problems

Published in print:
2018
Published Online:
May 2018
ISBN:
9780190623784
eISBN:
9780190623814
Item type:
chapter
Publisher:
Oxford University Press
DOI:
10.1093/oso/9780190623784.003.0008
Subject:
Economics and Finance, Financial Economics

This chapter provides a detailed examination of pharmaceutical pricing strategies in the United States. It points out that pharmaceutical expenditure as a share of total healthcare spending has ... More


The Business of Medicine

Jessica Flanigan

in Pharmaceutical Freedom: Why Patients Have a Right to Self Medicate

Published in print:
2017
Published Online:
August 2017
ISBN:
9780190684549
eISBN:
9780190684570
Item type:
chapter
Publisher:
Oxford University Press
DOI:
10.1093/oso/9780190684549.003.0006
Subject:
Philosophy, Political Philosophy

Policies that prohibit manufacturers from charging high prices for drugs potentially hinder patients’ access to drugs. Popular concerns about high drug prices cannot generally justify policies that ... More


Access to Pharmaceuticals: Role of State, Industry, and Market

S. Srinivasan and Malini Aisola

in Equity and Access: Health Care Studies in India

Published in print:
2018
Published Online:
July 2019
ISBN:
9780199482160
eISBN:
9780199097746
Item type:
chapter
Publisher:
Oxford University Press
DOI:
10.1093/oso/9780199482160.003.0008
Subject:
Sociology, Health, Illness, and Medicine, Social Stratification, Inequality, and Mobility

Affordability, accessibility, availability, and rationality of medicines are a big challenge in India. Notwithstanding the tag of 'pharmacy of the developing world', the India story is one of poverty ... More


Polypharmacy: The Problem with Pills

Frederick M. Barken

in Out of Practice: Fighting for Primary Care Medicine in America

Published in print:
2011
Published Online:
August 2016
ISBN:
9780801449765
eISBN:
9780801460609
Item type:
chapter
Publisher:
Cornell University Press
DOI:
10.7591/cornell/9780801449765.003.0004
Subject:
Public Health and Epidemiology, Public Health

This chapter comments on doctors' propensity to overprescribe, a practice known as polypharmacy. Polypharmacy simply means “many drugs,” and may be quite appropriate in certain cases, such as an ... More


IPRs, Public Health and the Pharmaceutical Industry: Issues in the Post-2005 TRIPS Agenda

Benjamin Coriat and Luigi Orsenigo

in Intellectual Property Rights: Legal and Economic Challenges for Development

Published in print:
2014
Published Online:
August 2014
ISBN:
9780199660759
eISBN:
9780191749186
Item type:
chapter
Publisher:
Oxford University Press
DOI:
10.1093/acprof:oso/9780199660759.003.0007
Subject:
Economics and Finance, Economic Systems

This chapter reviews the main problems and the available evidence concerning the relationships between IPRs, innovation and welfare in pharmaceuticals. In the first part, it examines first—as a ... More


The Right to Treatment

Peter Piot

in AIDS Between Science and Politics

Published in print:
2015
Published Online:
November 2015
ISBN:
9780231166263
eISBN:
9780231538770
Item type:
chapter
Publisher:
Columbia University Press
DOI:
10.7312/columbia/9780231166263.003.0006
Subject:
Public Health and Epidemiology, Public Health

This chapter discusses the quest for an effective treatment for AIDS and efforts to provide universal access to treatment. In the early 1980s there were no effective treatments against viruses on the ... More


The Defensive Coalition on the Offensive: National Industry and Argentina’s Market-Preserving Patent System

Kenneth C. Shadlen

in Coalitions and Compliance: The Political Economy of Pharmaceutical Patents in Latin America

Published in print:
2017
Published Online:
August 2017
ISBN:
9780199593903
eISBN:
9780191845574
Item type:
chapter
Publisher:
Oxford University Press
DOI:
10.1093/oso/9780199593903.003.0006
Subject:
Political Science, Political Economy

This chapter analyses the political economy of continuity in Argentina’s minimalist response to the new global order in intellectual property. The choices made in the 1990s facilitated Argentina’s ... More


Reversing the Tide: Lessons from the Movement for AIDS Treatment Access

Joia S. Mukherjee

in An Introduction to Global Health Delivery

Published in print:
2017
Published Online:
December 2017
ISBN:
9780190662455
eISBN:
9780190662486
Item type:
chapter
Publisher:
Oxford University Press
DOI:
10.1093/oso/9780190662455.003.0002
Subject:
Public Health and Epidemiology, Public Health

This chapter focuses on the emergence of the AIDS pandemic. It covers the emergence of symptoms associated with HIV, the discovery of the virus, and the understanding of its transmission. It ... More


View: